Shock energy study for heart rhythm conversion in atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests whether using a specific “shock energy” during electrical cardioversion works safely and effectively for people with persistent atrial fibrillation. You might be eligible if your cardioversion is planned (not an emergency) and your doctors determine you can safely take blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old.
- You are having electrical cardioversion for atrial fibrillation in a planned setting (elective outpatient or non-emergency inpatient).
- Your doctor says you can take blood thinners (anticoagulation).
- You’ve been on blood thinners reliably for at least 3 weeks before cardioversion OR your atrial fibrillation started within 48 hours of the cardioversion OR a test (transesophageal echocardiogram) shows no blood clot in the left atrium.
- Atrial flutter is not the main rhythm being treated, and you must be able to consent to both the cardioversion and study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method using two electrical shocks to help restore a normal heart rhythm in patients with persistent atrial fibrillation (a condition where the heart's upper chambers beat irregularly). The goal is to see if this technique is safe and effective.
This trial compares two ways of doing cardioversion (a procedure to restore normal heart rhythm) for people with persistent atrial fibrillation. It aims to see if one approach leads to a better recovery and fewer complications.
This study looks at whether giving an electrical shock (cardioversion) right after heart surgery can help people with long-lasting atrial fibrillation keep a normal heartbeat. It may help guide future treatment decisions for patients who have not gotten better with medication.
This study looks at how a heart rhythm procedure (cardioversion) affects quality of life in people with persistent atrial fibrillation (AF). It may help you understand whether a specific approach can improve day-to-day symptoms and well-being after treatment.
This study tests whether two different positions of the electrodes (pads) used for an electrical shock work equally well for people with atrial fibrillation or flutter. It may help improve how safely and effectively the shock restores a normal rhythm.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.